Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phasic and Tonic mGlu7 Receptor Activity Modulates the Thalamocortical Network.
Tassin V, Girard B, Chotte A, Fontanaud P, Rigault D, Kalinichev M, Perroy J, Acher F, Fagni L, Bertaso F. Tassin V, et al. Among authors: kalinichev m. Front Neural Circuits. 2016 Apr 25;10:31. doi: 10.3389/fncir.2016.00031. eCollection 2016. Front Neural Circuits. 2016. PMID: 27199672 Free PMC article.
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Elliott M, Favre-Guilmard C, Liu SM, Maignel J, Masuyer G, Beard M, Boone C, Carré D, Kalinichev M, Lezmi S, Mir I, Nicoleau C, Palan S, Perier C, Raban E, Zhang S, Dong M, Stenmark P, Krupp J. Elliott M, et al. Among authors: kalinichev m. Sci Adv. 2019 Jan 16;5(1):eaau7196. doi: 10.1126/sciadv.aau7196. eCollection 2019 Jan. Sci Adv. 2019. PMID: 30746458 Free PMC article.
A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo.
Donald S, Elliott M, Gray B, Hornby F, Lewandowska A, Marlin S, Favre-Guilmard C, Périer C, Cornet S, Kalinichev M, Krupp J, Fonfria E. Donald S, et al. Among authors: kalinichev m. Pharmacol Res Perspect. 2018 Nov 22;6(6):e00446. doi: 10.1002/prp2.446. eCollection 2018 Dec. Pharmacol Res Perspect. 2018. PMID: 30519475 Free PMC article.
Recombinant botulinum neurotoxin serotype A1 in vivo characterization.
Périer C, Martin V, Cornet S, Favre-Guilmard C, Rocher MN, Bindler J, Wagner S, Andriambeloson E, Rudkin B, Marty R, Vignaud A, Beard M, Lezmi S, Kalinichev M. Périer C, et al. Among authors: kalinichev m. Pharmacol Res Perspect. 2021 Oct;9(5):e00857. doi: 10.1002/prp2.857. Pharmacol Res Perspect. 2021. PMID: 34632725 Free PMC article.
The Expanding Therapeutic Utility of Botulinum Neurotoxins.
Fonfria E, Maignel J, Lezmi S, Martin V, Splevins A, Shubber S, Kalinichev M, Foster K, Picaut P, Krupp J. Fonfria E, et al. Among authors: kalinichev m. Toxins (Basel). 2018 May 18;10(5):208. doi: 10.3390/toxins10050208. Toxins (Basel). 2018. PMID: 29783676 Free PMC article. Review.
ADX71943 and ADX71441, novel positive allosteric modulators of the GABAB receptor with distinct central/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the rat.
Kalinichev M, Donovan-Rodriguez T, Girard F, Haddouk H, Royer-Urios I, Schneider M, Bate ST, Marker C, Pomonis JD, Poli S. Kalinichev M, et al. Eur J Pharmacol. 2017 Jan 15;795:43-49. doi: 10.1016/j.ejphar.2016.11.056. Epub 2016 Dec 1. Eur J Pharmacol. 2017. PMID: 27916555
51 results